Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

NCT03856047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

706

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: NNC0174-0833
DRUG: Placebo (NNC0174-0833)
DRUG: Liraglutide 3.0 mg
DRUG: Placebo (Liraglutide 3.0 mg)

Sponsor

Novo Nordisk A/S